ImaGenes Certified for NimbleGen DNA Methylation Services | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche NimbleGen said today that it has certified Berlin-based genomics services company ImaGenes to offer its DNA Methylation Analysis arrays.

ImaGenes passed the certification to become a Certified Service Provider for the DNA Methylation Analysis workflow, which is used in identifying novel genetic markers that can be used in diagnostic and prognostic development programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.